Introduction
============

It is apparent that obesity represents one of the foremost contributory factors leading to diabetes.^[@B1]^ Metabolic syndrome is associated with high risk for the development of diabetes and cardiovascular diseases (CVD).^[@B2]^ The greater risk of type 2 Diabetes Mellitus (DM) in the obese can, at least partly, be explained by changes in adipose tissue function.^[@B3]-[@B5]^ It is now well known that adipose tissues are active endocrine tissues that produce \>50 adipokines, including leptin, adiponectin, resistin, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), vascular endothelial growth factors, nerve growth factors, and haptoglobin.^[@B6]^

The recent interests in adipocyte derived factors have resulted in identification of a large group of adipocyte specific proteins in blood, such as adiponectin, acylation stimulating proteins, resistin and leptin.^[@B7]^ These adipocyte derived hormones are presently under intensive investigations concerning their involvement in the regulation of adipose tissue physiology, and in particular, their potential implication in insulin resistance, obesity and diabetes.^[@B8]^ Resistin is a protein hormone secreted by adipocytes which leads to insulin resistance and is considered to be an important link between obesity and diabetes.^[@B9]^ Resistin has been involved in the pathogenesis of obesity-mediated insulin resistance and type 2 DM. The expression and functional properties of adipocytokines and their effects on metabolism have been under intensive investigation. Indeed, studies on adipocytokines and their potential effects in human obesity and type 2 DM have implicated them in the pathogenesis of metabolic syndrome.^[@B10]^ However, still the true pathogenic mechanism that leads to accelerated atherogenesis in DM is still not known, because of its multi system ramifications. Elevated Lipoprotein(a) \[Lp(a)\] levels confer genetic predisposition to CVD and may be one of the links to accelerated atherogenesis in DM.^[@B11]-[@B13]^ Our previous reports have shown that Lp(a) is a marker of the presence, diffuseness and severity of CAD in Saudi adults.^[@B14]^

A large body of evidence have shown that the inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) is an independent predictor of cardiovascular events and it also predicts risk of incident hypertension and diabetes.^[@B15]^ Although it is apparent that inconsistencies remain in the data for a role of adipokines in obesity, there is a compelling evidence for their involvement in the etiology of insulin resistance and type 2 DM. The relationship among obesity, inflammatory markers (such as adipokines, phase reactant proteins), and insulin resistance (IR) has been investigated extensively in several populations but not explicitly in Saudi arabian population in which the prevalence of obesity and associated comorbidities is one of the highest in the world. Men have considerably lower plasma adiponectin levels than women, concordant with previous studies.^[@B16]^ Therefore we studied only one gender to exclude the possible confounding effect of gender on variables studied. This may partly relate to inhibitory effects of androgens on adiponectin levels.^[@B17]^

To the best of our knowledge there are few studies relating both resistin and adiponectin in normoglycemic subjects with obesity indices. Therefore, this project evaluated the phenotypic relationship between obesity indices, resistin, adiponectin and cardiovascular risk markers in normoglycemic healthy individuals.

Methodology
===========

***Subjects:***This cross-sectional study was conducted in the Department of Physiology College of Medicine, King Saud University, Riyadh. Patients were recruited from King Khalid University Hospital. The consent form was designed both in Arabic and English and was approved by the College of Medicine ethics review board. A total of 120 male subjects were selected for the study. All subjects underwent Body composition analysis.

***Laboratory Analysis:***Overnight fasting blood samples were collected, and analyzed for fasting blood glucose (FBG), total cholesterol (TC), Triglycerides (TG), Low density Lipoprotein (LDL), High density lipoprotein (HDL), adiponectin, resistin, Lp(a) and hsCRP. Human hsCRP and Lp(a) immunoassays were performed by quantitative standard sandwich ELISA technique using monoclonal antibody specific for these analytes with kits supplied by IBL International GMBH Germany. The results of patients with hsCRP values \>10 mg/L were discarded and were re-evaluated after 2-3 weeks. We followed the guidelines of the American Heart Association for measurement, evaluation and expression of hsCRP.^[@B18]^

***Statistical Analysis:***The data was analyzed by computer software program Statistical Package for Social Sciences (SPSS Version 19, Chicago, IL). Descriptive characteristics of the study patients were calculated as mean±SD (Standard Deviation) for continuous variables. The tests applied for statistical analysis were Student's t test for normally distributed and non-parametric Mann-Whitney U test for data which was not following normal distribution. Univariate correlations of Serum hsCRP with body indices, fat mass and other metabolic parameters were evaluated with both Spearman's rank order and Pearson correlations. Stepwise multiple regression analyses were performed to further indentify the most significant variables contributing to hsCRP levels. A p value of ≤0.05 was taken as statistically significant.

Results
=======

Anthropometric and biochemical profiles of participants included in this study are displayed in [Table-I](#T1){ref-type="table"} with correlation coefficients with hsCRP. We observed that BMI (r=0.326, p\<0.001), BFM (r=0.377, p\<0.001), BF% (r=0.326, p\<0.001), WHR (r=0.402, p\<0.001), Insulin (r=0.217, p=0.018) were positively correlated with hsCRP. However, serum adiponectin levels (r=0.189, p=0.0391) were negatively correlated with hsCRP.

###### 

Anthropometric and metabolic characteristics of the subjects and correlation coefficients with hsCRP.

  *Total Subjects N=120*   *Mean±SD*      *Minimum*   *Maximum*   *r*      *p value*
  ------------------------ -------------- ----------- ----------- -------- -----------
  Age years                40.16±11.81    21.00       71.00       0.186    0.044
  Height cm                167.42±8.21    147.00      187.00      -0.174   0.059
  Weight kg                78.85±14.17    45.80       125.00      0.160    0.084
  BMI kg/m2                28.13±4.80     15.60       42.30       0.326    \<0.001
  Fat Mass kg              24.08±8.58     6.20        52.70       0.351    \<0.001
  \% FAT                   30.01±7.58     12.50       49.80       0.377    \<0.001
  WHR                      0.95±0.07      0.77        1.16        0.402    \<0.001
  FBS mmol/l               5.04±0.91      2.90        5.60        -0.047   0.617
  Insulin uIU/ml           24.20±11.87    14.15       132.15      0.217    0.018
  HOMA-IR                  5.50±3.35      2.58        32.30       0.130    0.159
  HbA1c %                  5.01±0.60      2.90        5.91        -0.021   0.833
  TG mmol/l                1.14±0.72      1.29        6.20        0.115    0.281
  TC mmol/l                4.64±0.91      2.90        6.20        0.119    0.267
  HDL mmol/l               1.19±0.22      0.75        1.63        -0.073   0.504
  LDL mmol/l               2.83±0.79      1.61        4.48        0.029    0.786
  Adiponectin ng/ml        127.42±58.28   36.72       308.25      -0.115   0.216
  Resistin ng/ml           2.40±1.14      0.57        5.58        0.088    0.342
  Lp(a) mg/dl              24.45±20.55    2.00        90.04       0.106    0.252
  hsCRP mg/L               3.75±2.36      0.81        9.80                 

Data are expressed as Mean±SD with ranges.

BMI, body mass index; % Fat, percent fat mass; HOMA-IR, homeostasis model assessment of insulin resistance; FBG, fasting blood glucose; TC, total cholesterol; TG, Triglycerides; LDL, Low density Lipoprotein; HDL, High density lipoprotein; Lp(a), Lipoprotein(a); high-sensitivity C-reactive protein (hsCRP)

[Table-II](#T2){ref-type="table"} shows comparison of Anthropometric and biochemical profiles, adipokines and CV risk markers between obese and non obese subjects. It was observed that obese subjects had siognificantly higher FBS (p=0.0466), HOMA-IR (p=0.0002), HbA1c (p=0.0366), TG (p=0.0198), hsCRP (p=0.0096) levels. While adiponectin levels were significantly lower in obese subjects compared to non obese subjects (p=0.0551).

In univariate regression analysis keeping hsCRP as dependant variable we observed that WHR, BFM, BF%, BMI and adiponectin were significant predictors However, no correlation was observed with resistin. ([Fig.1](#F1){ref-type="fig"})

The degree to which obesity markers independently predicted hsCRP was examined in a series of multiple regression models. In these models, hsCRP was the dependent variable and obesity markers, adipokines, HOMAIR and lipids were the independent variables. In multiple regression analysis many variables became non significant predictors. Only WHR and adiponectin levels turned out to be independent predictors of hsCRP and this relationship was independent of age. ([Table-III](#T3){ref-type="table"})

Discussion
==========

We evaluated the relationship between obesity indices (BMI, WHR, BF%, BFM), hsCRP, adipokines and IR in Saudi population. To the best of our knowledge, this study is the first to compare the associations among obesity, inflammation, adipokines and IR in Saudis. Results from this study confirmed previously reported associations between markers of obesity (BMI and WHR) and IR measured by HOMA.^[@B19]-[@B21]^

###### 

Comparison of anthropometric and metabolic characteristics of between obese and non obese subjects.

                      *Non Obese*    *Obese*        *P value*
  ------------------- -------------- -------------- -----------
  Age                 40.18±10.99    40.12±13.34    0.9788
  Height              167±7.56       166.40±9.28    0.3224
  Weight              72.53±11.18    90.28±11.68    0.0000
  BMI kg/m2           25.56±3.40     32.85±2.99     0.0000
  Fat Mass kg         19.63±5.71     32.11±6.89     0.0000
  \% FAT              26.82±6.39     35.69±6.06     0.0000
  WHR                 0.92±0.05      1.01±0.06      0.0000
  FBS mmol/l          4.92±0.57      5.27±1.30      0.0446
  Insulin uIU/ml      23.28±13.82    25.91±6.78     0.2485
  HOMA-IR             4.75±1.40      5.97±1.99      0.0002
  HbA1c               4.94±0.57      5.20±0.59      0.0366
  TG mmol/l           1.06±0.51      1.37±0.73      0.0198
  TC mmol/l           4.64±0.93      4.64±0.91      0.9757
  HDL mmol/l          1.06±0.51      1.30±0.23      0.6933
  LDL mmol/l          2.83±0.80      2.81±0.80      0.9017
  Adiponectin ng/ml   130.04±54.91   112.53±42.84   0.0451
  Resistin ng/ml      2.42±1.15      2.40±1.13      0.9351
  Lp(a) mg/dl         24.79±21.95    23.85±17.98    0.8133
  hsCRP mg/L          3.33±2.00      4.48±2.74      0.0096

This study reports that serum adiponectin concentrations were inversely related to circulating hsCRP. Our data also confirms that BF% and BFM obesity are major determinants of plasma adiponectin concentrations. Higher levels of BF%, BFM and WHR, reflecting total and visceral adiposity, were associated with an additive fall in plasma adiponectin concentrations. Similar to our reports Matsushita et al.^[@B22]^ performed a cross-sectional study of 624 Japanese middle-aged men and found that adiponectin level was a more significant predictor compared to TNFa, IL-6 or hsCRP for prevalent metabolic syndrome. In line with our results previous studies have also shown that obesity, especially visceral obesity, is associated with low-grade inflammation, which is characterized by an increase in plasma concentration of inflammatory markers such as hsCRP, TNF-α and IL-6.^[@B23]^

![Linear regression analysis of hsCRP (mg/L) as dependant variable (Y axis) with body indices and adipokines as independent variables (X axis).](PJMS-029-021-g001){#F1}

Consistent with previous findings, we observed significant association among hsCRP, BMI, WHR, BF% & BFM in Saudis.^[@B24]-[@B26]^ Unlike most other adipocytederived hormones, circulating adiponectin levels are decreased in obesity.^[@B27],[@B28]^ Adiponectin increases fatty acid oxidation and directly sensitizes the body to insulin.^[@B29],[@B30]^

The degree to which hsCRP may be predicted by markers of obesity were also assessed in different univariate and multivariate regression models. Taken together, our model showed that adiponectin and WHR were independent predictors of hsCRP for CV risk. Following the above observation, it is reasonable to suggest that the relationship between adipokines and hsCRP is to a significant extent dependent on visceral adiposity especially WHR.

Potential limitation of our study is its cross-sectional design from which we are not able to provide a strong causative conclusion. Secondly, our subjects were relatively homogenous with lower CVD risks because all were normoglycemic. Although various confounding factors such as sex, age and cigarette smoking have been minimized, we should be cautious to apply the conclusion to general population. Therefore, further extending the study samples to women and other ethnic populations with various CVD risks is needed.

###### 

Multiple regression analysis for prediction of hsCRP in 120 healthy middle aged men.

                       *Standardized Coefficients Beta*   *P value*   *95.0% Confidence Interval for B (Lower-Upper)*
  -------------------- ---------------------------------- ----------- -------------------------------------------------
      Age years         -.019                              .897        -.064-.057
   Fat Mass kg          .575                               .252        -.132-.492
   Weight kg            -.688                              .329        -.370-.126
   Height cm            .254                               .580        -.196-.347
   BF%                  -.218                              .579        -.340-.192
   WHR                  .669                               .011        5.474-41.305
   BMI kg/m2            -.057                              .913        -.627-.562
   FBS mmol/dl          .410                               .370        -1.941-5.138
   Insulin uIU/ml       1.110                              .123        -.127-1.036
   HOMA-IR              -1.110                             .161        -4.529-.772
   HbA1c%               .026                               .930        -2.202-2.406
   TG mmol/L            -.038                              .799        -1.087-.841
   TC mmol/L            .236                               .362        -.761-2.054
   HDL mmol/L           -.039                              .748        -3.154-2.278
   LDL mmol/L           -.444                              .070        -2.952-.117
   Adiponectin ng/ml    -.251                              .049        -.021- -.001
   Resistin ng/ml       .067                               .612        -.409-.688
   Lp(a) mg/dl          .150                               .211        -.010-.043

Conclusions
===========

Obese individuals have significantly higher levels of hsCRP levels and lower adiponectin levels than non obese subjects. Serum adiponectin levels and WHR are independent predictors of hsCRP levels in normoglycemic subjects.
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